Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...
Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $435 and keeps a Neutral rating on the shares. The firm ...
Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...
Anne M. Szostak, a director at IDEXX Laboratories Inc. (NASDAQ:IDXX), recently sold 3,000 shares of the company's common stock. The shares were sold at an average price of $465.945, totaling ...
Shares of IDEXX Laboratories Inc. IDXX rallied 1.12% to $464.91 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results